Skip to main content
eScholarship
Open Access Publications from the University of California

Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy

  • Author(s): Piccioni, DE
  • Selfridge, J
  • Mody, RR
  • Chowdhury, R
  • Li, S
  • Lalezari, S
  • Wawrzynski, J
  • Quan, J
  • Zurayk, M
  • Chou, AP
  • Sanchez, DE
  • Liau, LM
  • Ellingson, BM
  • Pope, WB
  • Nghiemphu, PL
  • Green, RM
  • Wang, H-J
  • Yong, WH
  • Elashoff, R
  • Cloughesy, TF
  • Lai, A
  • et al.
Main Content
Current View